Protalix BioTherapeutics, Inc. (NY:PLX)
Delayed: 5.20 +0.04 (0.78%)
Trade Now!
Previous Close $5.16    52 Week High $6.80 
Open $5.16    52 Week Low $4.71 
Day High $5.26    P/E N/A 
Day Low $5.07    EPS $-0.13 
Volume 178,684       

Friends, Peers and Foes (?): PFE, SGYP, MDVN, AMRN IRWD (more...)

May 9, 2013 05:16 PM Form 10-Q Protalix BioTherapeutics For: Mar 31
May 8, 2013 07:30 AM Protalix BioTherapeutics to Present at the Oppenheimer 14th Annual Israeli Conference
Apr 29, 2013 07:35 AM Form 8-K Protalix BioTherapeutics For: Apr 29
Apr 29, 2013 07:30 AM UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
Apr 2, 2013 07:44 AM Form 8-K Protalix BioTherapeutics For: Apr 02
Apr 2, 2013 07:32 AM Protalix Bio (PLX) Treats First Patient in PRX-112 Phase I
Apr 2, 2013 07:30 AM Protalix BioTherapeutics Treats First Gaucher Patient in Phase I Study With PRX-112, an Orally-Administered Enzyme Treatment of Gaucher Disease
Mar 19, 2013 09:46 AM Brazilian Approval a Positive for Protalix (PLX) - Oppenheimer
Mar 18, 2013 02:17 PM Pfizer (PFE), Protalix (PTX) UPLYSO Receives Approval in Brazil
Feb 13, 2013 07:43 AM Protalix BioTherapeutics (PLX) to Present Data on ELELYSO
View All Articles

Entities mentioned with PLX

View All Entities